^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    plozalizumab (TAK-202)

    i
    Other names: TAK-202, MLN-1202, anti-CCR2 monoclonal antibody, MLN1202, MLN 1202, TAK 202, TAK202
    Associations
    News
    Trials
    Company:
    Takeda
    Drug class:
    CCR2 receptor inhibitor
    Related drugs:
    Associations
    News
    Trials